Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Douglas L, Sheridan"'
Publikováno v:
Blood. 138:3153-3153
Fetal/neonatal alloimmune thrombocytopenia (FNAIT) is a life-threatening bleeding disorder caused by maternal alloantibodies directed against paternally inherited antigens present on the surface of fetal and neonatal platelets. The human platelet all
Autor:
Gregers R. Andersen, Janus Asbjørn Schatz-Jakobsen, Yuchun Zhang, Douglas L. Sheridan, Alyssa Neill, Krista Johnson
Publikováno v:
Schatz-Jakobsen, J A, zhang, Y, Johnson, K, Neill, A, Sheridan, D & Andersen, G R 2016, ' Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway ', Journal of Immunology, vol. 197, no. 1, pp. 337-344 . https://doi.org/10.4049/jimmunol.1600280
Eculizumab is a humanized mAb approved for treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Eculizumab binds complement component C5 and prevents its cleavage by C5 convertases, inhibiting release
Autor:
Melissa A. Lasaro, Yuchun Zhang, Fang Sun, Paul P. Tamburini, Zhao-Xue Yu, Rekha Patel, Yi Wang, Keith Bouchard, Bruce A. Andrien, Douglas L. Sheridan, Andre Marozsan
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195909 (2018)
PLoS ONE
PLoS ONE
Eculizumab, a monoclonal antibody (mAb) directed against complement protein C5, is considered to be the current standard of care for patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. This study describes
Autor:
Rekha Patel, Yi Wang, Douglas L. Sheridan, Andre Marozsan, Keith Bouchard, Melissa A. Lasaro, Zhao-Xue Yu, Bruce A. Andrien, Paul P. Tamburini, Yuchun Zhang
Publikováno v:
Immunobiology. 221:1158
Autor:
Grace R. Jeschke, Matthew C. Good, Xiuqiong Zhou, Nancy M. Hollingsworth, Bruce Stillman, Wendell A. Lim, David F. Stern, Philip M. Kim, Richelle Sopko, Miri Jwa, Brenda J. Andrews, Mark Gerstein, Janine Mok, Stacy Piccirillo, Attila Remenyi, Ved Desai, Michael Snyder, Hugo Y. K. Lam, Sirlester A. Parker, Hengyao Niu, Holly E. Sassi, Clarence S.M. Chan, Benjamin E. Turk, Elisabetta Cameroni, Yi-Jun Sheu, Jia Lin Nianhan Ma, Claudio De Virgilio, Douglas L. Sheridan
Phosphorylation is a universal mechanism for regulating cell behavior in eukaryotes. Although protein kinases target short linear sequence motifs on their substrates, the rules for kinase substrate recognition are not completely understood. We used a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8687e86b66c571a7fd1182e9885281
http://doc.rero.ch/record/17524/files/vir_dpk_sm.pdf
http://doc.rero.ch/record/17524/files/vir_dpk_sm.pdf
Publikováno v:
The Journal of biological chemistry. 283(28)
Mitogen-activated protein kinases (MAPKs) mediate cellular responses to a wide variety of extracellular stimuli. MAPK signal transduction cascades are tightly regulated, and individual MAPKs display exquisite specificity in recognition of their targe
Autor:
Keith Bouchard, Leonardo Sahelijo, Paresh Soni, Bruce A. Andrien, David Mitchell, Richard Larouche, Rekha Patel, Susan Macdonald, Paul P. Tamburini, Yi Wang, Douglas L. Sheridan, Yuchun Zhang, Melissa A. Lasaro, Arshad Mujeebuddin, Zhao-Xue Yu
Publikováno v:
Blood. 126:4777-4777
Introduction: ALXN1210 is a humanized monoclonal antibody (mAb), with a sequence closely related to eculizumab (Soliris®). ALXN1210 binds specifically to human complement protein C5 and was engineered to eliminate the formation of C5a and the termin
Publikováno v:
Neuroscience. 141(2)
The green fluorescent protein can be fused to the ends of a mature glutamate receptor subunit to produce functional, fluorescent receptors. However, there are good reasons to search for internal regions of receptor subunits that can tolerate green fl
Autor:
Sonjoo Son, Daniela Gorbecheva, John Tierney, Michelle Ripp, Linda M. Mascavage, Douglas L. Sheridan
Publikováno v:
Heterocyclic Communications. 11
Publikováno v:
Molecular pharmacology. 66(3)
The neurotoxin 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP) damages forebrain serotonin (5-HT) and norepinephrine (NE) nerve terminals while sparing striatal dopaminergic innervation. Previous studies suggest that 2'-NH(2)-M